At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 80 enrolled
Drug / intervention
Adherence to topical standard therapy assessedbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized Single-blind Study on the Adherence to Treatment With Topical Methylprednisolone Aceponate (Advantan®) in Different Vehicles (AD-HERE)
In Brief
A Phase 4 clinical trial evaluating Adherence to topical standard therapy assessed for Adherence, Patient and Chronic Eczema. Completed, enrolled 80 participants across 1 site.
Detailed Summary
Untersuchung der Adhärenz zur topischen Standardtherapie bei Patienten mit chronischem Handekzem in Abhängigkeit von der Galenik
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAdherence, Patient, Chronic Eczema
CountriesGermany
CollaboratorsBayer
Timeline
Phase 4CompletedFinished
2020202120222023202420252026
First PostedJul 2019
Enrollment StartDec 2020
Primary CompletionMar 2022
Study CompletionApr 2022
TodayJul 2026
First PostedJul 11, 2019
Enrollment StartDec 2, 2020
Primary CompletionMar 11, 2022
Study CompletionApr 14, 2022
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 7.0 years ago
Interventions
Adherence to topical standard therapy assessedbehavioral
Adherence defined as percentage of patients applying at least aimed daily dose